ArticleOncotarget2017

Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".

Anja Feldmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.